Detalhe da pesquisa
1.
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Mult Scler
; 29(8): 904-925, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293841
2.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Mult Scler
; 29(14): 1841-1848, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728389
3.
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs.
Eur J Neurol
; 30(8): 2144-2176, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37293849
4.
The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria.
Brain
; 145(11): 3931-3942, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727945
5.
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis.
Mult Scler
; 28(6): 950-957, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841948
6.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Mult Scler
; 28(9): 1424-1456, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196927
7.
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Mult Scler
; 28(7): 1138-1145, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35475363
8.
Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset.
Eur J Neurol
; 29(4): 1075-1081, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33609298
9.
Vaccinations in multiple sclerosis patients receiving disease-modifying drugs.
Curr Opin Neurol
; 34(3): 322-328, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709979
10.
Multiple sclerosis is associated with higher comorbidity and health care resource use: A population-based, case-control study in a western Mediterranean region.
Eur J Neurol
; 28(12): 4124-4134, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34293826
11.
COVID-19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response.
Eur J Neurol
; 28(10): 3384-3395, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340215
12.
Prevalence of age-related macular degeneration among optometric telemedicine users in Spain: a retrospective nationwide population-based study.
Graefes Arch Clin Exp Ophthalmol
; 259(7): 1993-2003, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576860
13.
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS.
Mult Scler
; 26(13): 1658-1669, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610739
14.
Rethinking vaccination in multiple sclerosis: The way forward.
Mult Scler
; 29(11-12): 1351-1352, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786980
15.
Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.
Mult Scler
; 24(6): 721-727, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445084
16.
Disability progression markers over 6-12 years in interferon-ß-treated multiple sclerosis patients.
Mult Scler
; 24(3): 322-330, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28287331
17.
Epidemiology of NMOSD in Catalonia: Influence of the new 2015 criteria in incidence and prevalence estimates.
Mult Scler
; 24(14): 1843-1851, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28984163
18.
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis.
Mult Scler
; 24(2): 96-120, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353550
19.
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.
Mult Scler
; 22(11): 1386-1396, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27207462
20.
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
Brain
; 138(Pt 7): 1863-74, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25902415